Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM
Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM
Active, not recruiting · NCT03673826 · Registry updated 2023-11-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM | Blood Protein Disorders, Hemic and Lymphatic Diseases, Hypergammaglobulinemia, hematologic disorder, immune system disorder, immunoproliferative disorder, monoclonal gammopathy, neoplasm, precancerous condition, smoldering plasma cell myeloma | Active, not recruiting | Phase 2 | 2023-11-01 | NCT03673826 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 27 |
16 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CZ-Brno-UHBRNO | Brno | Czechia | 1 |
| CZ-Ostrava-Poruba-FNO | Ostrava | Czechia | 1 |
| IT-Ancona-UMBERTOA | Ancona | Italy | 1 |
| IT-Bologna-MALPHIGI | Bologna | Italy | 3 |
| IT-Brescia-SPEDALICIVILI | Brescia | Italy | 1 |
| IT-Roma-SAPIENZA | Roma | Italy | 3 |
| IT-Torino-MOLINETTE | Torino | Italy | 1 |
| NL-Amsterdam-VUMC | Amsterdam | Netherlands | 10 |
| NL-Den Bosch-JBZ | 's-Hertogenbosch | Netherlands | 14 |
| NL-Hoofddorp-SPAARNEGASTHUIS | Hoofddorp | Netherlands | 7 |
| NL-Leeuwarden-MCL | Leeuwarden | Netherlands | 10 |
| NL-Nijmegen-RADBOUDUMC | Nijmegen | Netherlands | 11 |
| NL-Rotterdam-ERASMUSMC | Rotterdam | Netherlands | 14 |
| NL-Sittard-Geleen-ZUYDERLAND | Sittard | Netherlands | 5 |
| NL-Utrecht-UMCUTRECHT | Utrecht | Netherlands | 16 |
| NO-Oslo-OSLOUH | Oslo | Norway | 6 |